[MELBOURNE, FL] -- Nanialei Golden, M.D., a MIMA Radiation Oncologist, has been chosen as a delegate for People to People Ambassador Programs.
As one of 15 physician members from USA, Dr. Golden will be promoting new technologies in Radiation Oncology to physicians in China. The two-week tour that begins Sept. 10, 2006 will include stops in Bejing, Hong Kong, Guilin and Shanghai.
Quote from Doctor – something on the order of: “This is an exciting opportunity for the US delegation to share our medical expertise with the Chinese physicians,” says Dr. Golden. “Our goal is to exchange ideas on state of the art cancer therapies. I am eager to share my experience and knowledge in different radiation modalities and learn how Traditional Chinese Medicine is integrated into Radiation Oncology.”
Radiation Oncologists treat patients with malignant and benign conditions using high energy radiation, for example X-rays or radioactive elements. Radiation is often integrated with other cancer treatments such as surgery or chemotherapy. Experts in various radiation delivery modalities, Radiation Oncologists have in-depth understanding of the way radiation interacts with tissues in the human body.
Dr. Golden, a partner with MIMA, is board-certified in Radiation Oncology by the American Board of Radiology. She completed her Radiation Oncology residency at Northwestern University in Chicago, Illinois. She spent time at University of California, San Francisco completing the H.H. Wong Fellowship in Gamma Knife Radiosurgery. Dr. Golden is currently the Director of Radiosurgery, Chairman of the weekly MIMA Cancer Center Tumor Board, and active on many cancer related committees including past Vice President of the South Brevard American Cancer Society Board of Directors. She has extensive experience in Image Guided Radiation Therapy (IGRT), Intensity Modulated Radiation Therapy (IMRT), Brachytherapy (including prostate and gynecologic malignancies), and Stereotactic Radiosurgery (SRS) and actively lectures on those innovative cancer therapeutics.